FRMD3 and liver dysplastic nodule: Our analyses in 3263 AA T2DM-ESRD cases and non-diabetic, non-nephropathy controls revealed an approximate 25–30% increase in DN risk with multiple FRMD3 SNPs in subjects not homozygous for the MYH9 E1 risk haplotype (or APOL1 risk variants).